Literature DB >> 9744531

The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism.

C Cavin1, D Holzhäuser, A Constable, A C Huggett, B Schilter.   

Abstract

The diterpenes cafestol and kahweol (C&K) have been identified in animal models as two potentially chemoprotective agents present in green and roasted coffee beans. It has been postulated that these compounds may act as blocking agents by producing a co-ordinated modulation of multiple enzymes involved in carcinogen detoxification. In this study, we investigated the effects of C&K against the covalent binding of aflatoxin B1 (AFB1) metabolites to DNA. Male Sprague-Dawley rats were treated with increasing amounts of a mixture of C&K in the diet (0-6200 p.p.m.) for 28 and 90 days. A dose-dependent inhibition of AFB1 DNA-binding was observed using S9 and microsomal subcellular fractions from C&K-treated rat liver in an in vitro binding assay. Significant inhibition was detected at 2300 p.p.m. and maximal reduction of DNA adduct formation to nearly 50% of the control value was achieved with 6200 p.p.m. of dietary C&K. Two complementary mechanisms may account for the chemopreventive action of cafestol and kahweol against aflatoxin B1 in rats. A decrease in the expression of the rat activating cytochrome P450s (CYP2C11 and CYP3A2) was observed, as well as a strong induction of the expression of the glutathione-S-transferase (GST) subunit GST Yc2, which is known to detoxify highly the most genotoxic metabolite of AFB1. These data and the previously demonstrated effects of C&K against the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced carcinogenesis at various tissue sites suggest the potential widespread effect of these coffee components against chemical carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9744531     DOI: 10.1093/carcin/19.8.1369

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

Review 1.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

2.  Coffee and liver - long way to go.

Authors:  Ajay K Duseja
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

3.  Coffee and tea intake and risk of head and neck cancer: pooled analysis in the international head and neck cancer epidemiology consortium.

Authors:  Carlotta Galeone; Alessandra Tavani; Claudio Pelucchi; Federica Turati; Deborah M Winn; Fabio Levi; Guo-Pei Yu; Hal Morgenstern; Karl Kelsey; Luigino Dal Maso; Mark P Purdue; Michael McClean; Renato Talamini; Richard B Hayes; Silvia Franceschi; Stimson Schantz; Zuo-Feng Zhang; Gilles Ferro; Shu-Chun Chuang; Paolo Boffetta; Carlo La Vecchia; Mia Hashibe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-06-22       Impact factor: 4.254

4.  Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study.

Authors:  Shane Johnson; Woon-Puay Koh; Renwei Wang; Sugantha Govindarajan; Mimi C Yu; Jian-Min Yuan
Journal:  Cancer Causes Control       Date:  2011-01-22       Impact factor: 2.506

5.  Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis.

Authors:  Li-Xuan Sang; Bing Chang; Xiao-Hang Li; Min Jiang
Journal:  BMC Gastroenterol       Date:  2013-02-25       Impact factor: 3.067

6.  Coffee, tea, caffeine intake, and the risk of cancer in the PLCO cohort.

Authors:  Mia Hashibe; Carlotta Galeone; Saundra S Buys; Lisa Gren; Paolo Boffetta; Zuo-Feng Zhang; Carlo La Vecchia
Journal:  Br J Cancer       Date:  2015-08-20       Impact factor: 7.640

7.  The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers.

Authors:  G Y Lai; S J Weinstein; D Albanes; P R Taylor; K A McGlynn; J Virtamo; R Sinha; N D Freedman
Journal:  Br J Cancer       Date:  2013-07-23       Impact factor: 7.640

Review 8.  Cafestol and Kahweol: A Review on Their Bioactivities and Pharmacological Properties.

Authors:  Yaqi Ren; Chunlan Wang; Jiakun Xu; Shuaiyu Wang
Journal:  Int J Mol Sci       Date:  2019-08-30       Impact factor: 5.923

Review 9.  Risk Factors, Pathogenesis, and Strategies for Hepatocellular Carcinoma Prevention: Emphasis on Secondary Prevention and Its Translational Challenges.

Authors:  Shen Li; Antonio Saviano; Derek J Erstad; Yujin Hoshida; Bryan C Fuchs; Thomas Baumert; Kenneth K Tanabe
Journal:  J Clin Med       Date:  2020-11-25       Impact factor: 4.241

10.  Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populations.

Authors:  Silmara Rodrigues Machado; Edison Roberto Parise; Luciana de Carvalho
Journal:  Braz J Infect Dis       Date:  2013-11-22       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.